IRE treatment for prostate symptoms in men with BPH
Part of Kidney & urinary clinical trials.
This trial tests a new minimally invasive procedure called irreversible electroporation (IRE)—which uses electrical pulses to treat prostate tissue—to relieve urinary symptoms caused by an enlarged prostate. The goal is to improve urinary flow and reduce bothersome symptoms without major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 50 or older
- You have been diagnosed with benign prostatic hyperplasia (BPH) causing urinary symptoms
- Your prostate is between 30–80 cubic centimeters in size (confirmed by ultrasound or MRI)
- Your urinary flow rate is slow (≤12 mL/sec) and you have significant symptom burden
- You have not had prior prostate surgery or minimally invasive treatments (such as TURP, laser, or UroLift)
- You do not have a pacemaker, defibrillator, or other implanted electrical devices that would interfere with the treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, non-surgical treatment called irreversible electroporation (IRE) for men with early-stage prostate cancer that hasn't spread. It uses short electrical pulses to destroy cancer cells while sparing healthy tissue nearby.
This trial tests a new focal treatment called IRE (irreversible electroporation) that uses electrical pulses to destroy prostate cancer cells while sparing healthy tissue. It is for men with intermediate-risk prostate cancer that has not spread outside the prostate gland.
This trial tests a newer, minimally invasive treatment (high-frequency irreversible electroporation) against standard treatments for an enlarged prostate causing urinary symptoms. The goal is to see if this approach relieves symptoms with fewer side effects.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
This trial compares two catheter-based treatments—TUMT and PAE—to see which better reduces severe urinary symptoms caused by an enlarged prostate (BPH). It may help you choose a treatment option if medicines are not suitable or you still have significant symptoms.
This study compares two minimally invasive devices (iTind and UroLift) to treat urinary symptoms caused by an enlarged prostate. It is for men whose symptoms are bothersome enough to need treatment.
Hear when a new Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.